Sintilimab: First Global Approval

Hoy, SM

Hoy, SM (reprint author), Springer, Private Bag 65901, Auckland 0754, New Zealand.

DRUGS, 2019; 79 (3): 341

Abstract

Sintilimab (Tyvyt((R))) is a fully human IgG4 monoclonal antibody that binds to programmed cell death receptor-1 (PD-1), thereby blocking the interact......

Full Text Link